111 layoffs, on the record
Every job cut, severance charge and restructuring 111 reported in its annual reports, 2023 to 2025, quoted from the filings.
Job cuts, severance and restructuring
Our summaryThe company's subsidiary 1 Pharmacy Technology repurchased ordinary shares from departed employees and unvested options at cost, paid in cash.
Word for word“In July 2024, the Company's subsidiary, Yao Wang Corporation Limited had repurchased an aggregate of 13,521,445 ordinary shares of 1 Pharmacy Technology from departed employees and unvested options at cost for total cash consideration of RMB 13,521 .” 20-F for 2024
111 has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from 111’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-04-30. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.